Publication | Open Access
Selective activation of angiotensin<scp>AT</scp><sub>2</sub>receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
85
Citations
48
References
2014
Year
Taken together, our results suggest that the AT2 receptor agonist, C21, may hold promise for patients with PH.
| Year | Citations | |
|---|---|---|
Page 1
Page 1